Company Filing History:
Years Active: 2022-2025
Title: Matthieu Pichaud: Innovator in Cancer Therapy
Introduction
Matthieu Pichaud is a notable inventor based in Cambridge, MA (US), recognized for his contributions to cancer therapy through innovative immunogenic compounds. With a total of 5 patents, Pichaud has made significant strides in the field of oncology, focusing on the development of antigenic peptides that can enhance the immune response against tumors.
Latest Patents
Among his latest patents, Pichaud has developed immunogenic compounds that comprise antigenic peptides with amino acid similarities to tumor antigens. These peptides are specifically selected from a group that includes sequences related to IL13RA2, which is crucial for targeting cancer cells effectively. His work aims to provide new therapeutic options for patients suffering from various forms of cancer.
Career Highlights
Pichaud's career is marked by his dedication to research and innovation in the biomedical field. He is currently associated with Enterome S.A., a company that focuses on developing novel immunotherapies. His expertise in immunogenic compounds has positioned him as a key player in the fight against cancer.
Collaborations
Throughout his career, Matthieu Pichaud has collaborated with esteemed colleagues, including Laurent Chene and Alban Mathieu. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking therapies.
Conclusion
Matthieu Pichaud's work in immunogenic compounds for cancer therapy exemplifies the impact of innovation in medicine. His contributions continue to pave the way for advancements in cancer treatment, showcasing the importance of research and collaboration in the field.